0001437749-22-027386.txt : 20221114
0001437749-22-027386.hdr.sgml : 20221114
20221114184328
ACCESSION NUMBER: 0001437749-22-027386
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221109
FILED AS OF DATE: 20221114
DATE AS OF CHANGE: 20221114
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JORDEN DAVID EMERSON
CENTRAL INDEX KEY: 0001313516
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32518
FILM NUMBER: 221388512
MAIL ADDRESS:
STREET 1: 2635 TECHNOLOGY FOREST BLVD.
CITY: THE WOODLANDS
STATE: TX
ZIP: 77381
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nuo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001091596
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 233011702
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8285 EL RIO, SUITE 150
CITY: HOUSTON
STATE: TX
ZIP: 77054
BUSINESS PHONE: 832-236-9060
MAIL ADDRESS:
STREET 1: 8285 EL RIO, SUITE 150
CITY: HOUSTON
STATE: TX
ZIP: 77054
FORMER COMPANY:
FORMER CONFORMED NAME: Nuo Therapeutics, Inc
DATE OF NAME CHANGE: 20141112
FORMER COMPANY:
FORMER CONFORMED NAME: CYTOMEDIX INC
DATE OF NAME CHANGE: 20000511
FORMER COMPANY:
FORMER CONFORMED NAME: AUTOLOGOUS WOUND THERAPY INC
DATE OF NAME CHANGE: 20000407
4
1
rdgdoc.xml
FORM 4
X0306
4
2022-11-09
0001091596
Nuo Therapeutics, Inc.
AURX
0001313516
JORDEN DAVID EMERSON
C/O NUO THERAPEUTICS, INC.
8285 EL RIO, SUITE190
HOUSTON
TX
77054
1
1
CEO/CFO
Common Stock
2022-11-09
4
S
0
30000
1.50
D
2107858
D
Common Stock
2022-11-09
4
S
0
30000
1.50
D
2077858
D
Common Stock
2022-11-09
4
S
0
27000
1.50
D
2050858
D
Common Stock
2022-11-09
4
S
0
20000
1.50
D
2030858
D
Common Stock
2022-11-09
4
S
0
20000
1.50
D
2010858
D
Common Stock
2022-11-09
4
S
0
13500
1.50
D
1997358
D
Common Stock
2022-11-09
4
S
0
10000
1.50
D
1987358
D
Common Stock
2022-11-09
4
S
0
7000
1.50
D
1980358
D
Common Stock
2022-11-09
4
S
0
5000
1.50
D
1975358
D
The transactions reported herein were made in private transactions to various persons whereby the shares of common stock acquired constitute "restricted" securities within the meaning of the Securities Act of 1933, as amended.
/s/ David Jorden
2022-11-14